These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6232810)

  • 1. Natural killer cell activity and T subpopulations in thalassemia major.
    Neri A; Brugiatelli M; Iacopino P; Callea V; Ronco F
    Acta Haematol; 1984; 71(4):263-9. PubMed ID: 6232810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subsets and specific T-cell immune response in thalassemia.
    Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
    Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of natural killer (NK) function in carriers and patients with thalassemia major.
    Goicoa MA; Estevez ME; Ballart IJ; Diez RA; Peñalver JA; de Miani SA; Sen L
    Nouv Rev Fr Hematol (1978); 1986; 28(2):75-9. PubMed ID: 3737398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired immune regulation in children and adolescents with hemophilia and thalassemia in Israel.
    Umiel T; Friedman E; Luria D; Cohen IJ; Kaplinsky H; Netzer L; Pecht M; Trainin N; Zaizov R
    Am J Pediatr Hematol Oncol; 1984; 6(4):371-8. PubMed ID: 6241995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload.
    Akbar AN; Fitzgerald-Bocarsly PA; de Sousa M; Giardina PJ; Hilgartner MW; Grady RW
    J Immunol; 1986 Mar; 136(5):1635-40. PubMed ID: 3005397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune status of Greek patients with beta-thalassemia major negative for anti-HIV.
    Choremi H; Sidiri E; Psarra K; Economidou J; Georgiopoulou P; Politi C; Roumeliotou A; Papaevangelou G
    Blut; 1987 May; 54(5):267-73. PubMed ID: 3105626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic studies in thalassemia major].
    Sen L; Goicoa MA; Nualart PJ; Ballart IJ; Palacios F; Diez RA; Estévez ME
    Medicina (B Aires); 1989; 49(2):131-4. PubMed ID: 2640481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
    Damle NK; Doyle LV; Bradley EC
    J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired cytotoxicity in Papillon-Lefèvre syndrome.
    Lundgren T; Parhar RS; Renvert S; Tatakis DN
    J Dent Res; 2005 May; 84(5):414-7. PubMed ID: 15840775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocyte subpopulations in thalassemia major.
    Guglielmo P; Cunsolo F; Calogero RD; Marra G; Lombardo M; Cacciola E; Sciacca S; Sortino G
    Birth Defects Orig Artic Ser; 1987; 23(5A):581-5. PubMed ID: 2961374
    [No Abstract]   [Full Text] [Related]  

  • 12. T-cell imbalances and NK activity in varicella-zoster virus infections.
    Cauda R; Prasthofer EF; Tilden AB; Whitley RJ; Grossi CE
    Viral Immunol; 1987; 1(2):145-52. PubMed ID: 2978454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of suppressive and natural killer-like activities associated with loss of alloreactivity in human "helper" T-lymphocyte clones.
    Pawelec G; Busch FW; Schneider EM; Rehbein A; Balko I; Wernet P
    Curr Top Microbiol Immunol; 1986; 126():121-30. PubMed ID: 2941238
    [No Abstract]   [Full Text] [Related]  

  • 14. [Deficit of natural killer cells (NK cells) in the peripheral blood of patients with atopic dermatitis].
    Reinhold U; Wehrmann W; Bauer R; Kreysel HW
    Hautarzt; 1986 Aug; 37(8):438-43. PubMed ID: 2944856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Splenectomy on Natural Killer Cell Levels in β-Thalassemia Major Patients.
    Kurtoğlu AU; Uğur S; Göçer M; Kurtoğlu E
    J Clin Lab Anal; 2024 May; 38(9):e25046. PubMed ID: 38814004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological status of thalassemia syndrome.
    Ezer U; Gülderen F; Culha VK; Akgül N; Gürbüz O
    Pediatr Hematol Oncol; 2002; 19(1):51-8. PubMed ID: 11787867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.
    Kaplan J; Sarnaik S; Gitlin J; Lusher J
    Blood; 1984 Jul; 64(1):308-10. PubMed ID: 6234037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte changes in beta-thalassaemia major.
    Musumeci S; Schiliro G; Romeo MA; Sciotto A; Rosalba A; Pizzarelli G
    Arch Dis Child; 1979 Dec; 54(12):954-7. PubMed ID: 316991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell functions in infants and children with beta-thalassemia.
    Khalifa AS; Maged Z; Khalil R; Sabri F; Hassan O; el-Alfy M
    Acta Haematol; 1988; 79(3):153-6. PubMed ID: 3128038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.